ScinoPharm Granted US Patent for Novel Crystal Forms ScinoPharm, an active pharmaceutical ingredient (API) specialist, announced it has been granted US Patent No. 7,435,818 entitled ¡§Novel Crystal Forms of Irinotecan Hydrochloride.¡¨
(Filed: Sun Nov 30 2008)